Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5347
Gene Symbol: PLK1
PLK1
0.010 Biomarker disease BEFREE Despite substantial response rates, clinical use of the PLK inhibitor volasertib has been hampered by elevated side effects such as neutropenia and infections. 31758597 2020
Entrez Id: 718
Gene Symbol: C3
C3
0.010 Biomarker disease BEFREE The ANCA-positive cocaine-levamisole cohort at onset were characterized by younger age (45 ± 12 vs 53 ± 14 years, p = 0.04), superficial skin necrosis (82% vs 54%, p = 0.036), depressed complement C3 (27% vs 4%, p = 0.33), antiphospholipid antibodies (50% vs 4%, p < 0.001), neutropenia (18% vs 0%, p = 0.044), and elevated antimyeloperoxidase (MPO) antibody levels (100% vs 67%, p < 0.001). 30273264 2020
Entrez Id: 55964
Gene Symbol: SEPTIN3
SEPTIN3
0.010 GeneticVariation disease BEFREE As of Sept 3, 2018 (the date up to which updated safety data were available), the most common grade 3-4 adverse events were neutropenia (38 [8%] of 453 patients in the atezolizumab group vs 36 [8%] of 437 patients in the placebo group), peripheral neuropathy (25 [6%] vs 12 [3%]), decreased neutrophil count (22 [5%] vs 16 [4%]), and fatigue (17 [4%] vs 15 [3%]). 31786121 2020
Entrez Id: 54205
Gene Symbol: CYCS
CYCS
0.010 Biomarker disease BEFREE Leucopenia occurred more often in the CYC group compared to the TwHF group (P = 0.034). 31713733 2020
Entrez Id: 9048
Gene Symbol: ARTN
ARTN
0.010 Biomarker disease BEFREE Rifabutin is the preferred rifamycin for adults on PI-based ART; only one study has evaluated its use among children on PIs and two of six children developed treatment-limiting neutropenia. 31139825 2019
Entrez Id: 181
Gene Symbol: AGRP
AGRP
0.010 Biomarker disease BEFREE Rifabutin is the preferred rifamycin for adults on PI-based ART; only one study has evaluated its use among children on PIs and two of six children developed treatment-limiting neutropenia. 31139825 2019
Entrez Id: 238
Gene Symbol: ALK
ALK
0.010 GeneticVariation disease BEFREE <b>Conclusion:</b> In patients with non-small-cell lung cancer, incidence of grade 3-4 neutropenia with ALK-targeted therapy is not significantly different compared with chemotherapy. 31116035 2019
Entrez Id: 6606
Gene Symbol: SMN1
SMN1
0.010 Biomarker disease BEFREE The results of our study revealed that during the first week, there were significant elevations of fibrin, tissue factor expressions, and prothrombin time (PT) coupled with neutropenia without significant changes in liver fibrosis markers such as TGF-β, α-SMA and collagen deposition. 31158377 2019
Entrez Id: 3425
Gene Symbol: IDUA
IDUA
0.010 Biomarker disease BEFREE The toxicity of the FLAG-IDA courses is generally more severe than for the FLAG courses, with marked neutropenia and thrombocytopenia. 30887181 2019
Entrez Id: 7001
Gene Symbol: PRDX2
PRDX2
0.010 Biomarker disease BEFREE Intravenous administration of Prx2 in animals at a concentration of 20 µg/g 15 min before exposure to ionizing radiation contributes to a significantly higher survival rate, suppresses the development of leucopenia and thrombocytopenia, as well as protects the bone marrow cells from genome DNA damage. 30605715 2019
Entrez Id: 3426
Gene Symbol: CFI
CFI
0.010 GeneticVariation disease BEFREE Neutropenia was a common high-grade (19%) treatment-related adverse event at ≥ 64 mg. Half-life of CFI-400945 was 9 h, with C<sub>max</sub> achieved 2-4 h following dosing. 31303643 2019
Entrez Id: 83666
Gene Symbol: PARP9
PARP9
0.010 Biomarker disease BEFREE The patients were divided into two groups immunocompetent and immunocompromised that is, patients with significant neutropenia <500 neutrophils/μl for longer than 10 days. microscopy, culture, identification of isolates were done and some specilised tests on serum and BAL for antigen detection were performed. 30429396 2019
Entrez Id: 6607
Gene Symbol: SMN2
SMN2
0.010 Biomarker disease BEFREE The results of our study revealed that during the first week, there were significant elevations of fibrin, tissue factor expressions, and prothrombin time (PT) coupled with neutropenia without significant changes in liver fibrosis markers such as TGF-β, α-SMA and collagen deposition. 31158377 2019
Entrez Id: 144125
Gene Symbol: OR2AG1
OR2AG1
0.010 Biomarker disease BEFREE The endpoint for HT was grade ≥3 (HT3+) and grade ≥2 (HT2+) leukopenia, neutropenia, anemia and thrombocytopenia. 31024846 2019
Entrez Id: 84618
Gene Symbol: NT5C1A
NT5C1A
0.010 Biomarker disease BEFREE Dyslipidemia, lymphoceles, and impaired wound healing were more frequent with mTORi-CNI and diarrhea and leukopenia were more frequent with MMF/MPA-CNI. 31343574 2019
Entrez Id: 3692
Gene Symbol: EIF6
EIF6
0.010 Biomarker disease BEFREE We extend the benign prognostic significance of del(20)(q) and loss of EIF6 to the haematological features of these patients, consistently characterized by mild hypoplastic BM, no or mild neutropenia, anaemia and thrombocytopenia. 30585299 2019
Entrez Id: 1992
Gene Symbol: SERPINB1
SERPINB1
0.010 Biomarker disease BEFREE Serpin B1 defect and increased apoptosis of neutrophils in Cohen syndrome neutropenia. 30843084 2019
Entrez Id: 3106
Gene Symbol: HLA-B
HLA-B
0.010 GeneticVariation disease BEFREE We now know that the genetic etiology of clozapine-associated neutropenia is complex and is likely to involve variants from several genes including HLA-DQB1, HLA-B and SLCO1B3/SLCO1B7. 30767710 2019
Entrez Id: 9663
Gene Symbol: LPIN2
LPIN2
0.010 GeneticVariation disease BEFREE Compound heterozygous LPIN2 pathogenic variants in a patient with Majeed syndrome with recurrent fever and severe neutropenia: case report. 31727123 2019
Entrez Id: 9051
Gene Symbol: PSTPIP1
PSTPIP1
0.010 GeneticVariation disease BEFREE PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome: A rare cause of childhood neutropenia associated with systemic inflammation and hyperzincemia. 30198636 2019
Entrez Id: 89845
Gene Symbol: ABCC10
ABCC10
0.010 GeneticVariation disease BEFREE Our results indicate that genetic variation in the ABCC10 gene is associated with neutropenia for docetaxel treatment. 30890141 2019
Entrez Id: 3119
Gene Symbol: HLA-DQB1
HLA-DQB1
0.010 GeneticVariation disease BEFREE We now know that the genetic etiology of clozapine-associated neutropenia is complex and is likely to involve variants from several genes including HLA-DQB1, HLA-B and SLCO1B3/SLCO1B7. 30767710 2019
Entrez Id: 92609
Gene Symbol: TIMM50
TIMM50
0.010 GeneticVariation disease BEFREE Whole-exome sequencing identified compound heterozygous mutations in TIMM50 (c.[341 G>A];[805 G>A]) in a boy with West syndrome, optic atrophy, neutropenia, cardiomyopathy, Leigh syndrome, and persistent 3-MGA-uria. 31058414 2019
Entrez Id: 10998
Gene Symbol: SLC27A5
SLC27A5
0.010 Biomarker disease BEFREE The patients were divided into two groups immunocompetent and immunocompromised that is, patients with significant neutropenia <500 neutrophils/μl for longer than 10 days. microscopy, culture, identification of isolates were done and some specilised tests on serum and BAL for antigen detection were performed. 30429396 2019
Entrez Id: 4493
Gene Symbol: MT1E
MT1E
0.010 Biomarker disease BEFREE Of 13, 9 treated at the MTD required dose modification, most for neutropenia (5). 31074316 2019